ArticleRSC advances2020
Two groups of copper
ZhaoGuo Hong, Chu Zheng, Bi Luo, Xin You, HeDong Bian, Hong Liang, ZhenFeng Chen, FuPing Huang
Open access · goldAbstract read
In one paragraphArticle in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 2 institutions in 1 country.
ZhaoGuo HongState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
Chu ZhengState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
Bi LuoState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
Xin YouState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
HeDong BianSchool of Chemistry and Chemical Engineering, Guangxi University for Nationalities, Key Laboratory of Chemistry and Engineering of Forest Products Nanning 530008 PR China.ORCID https://orcid.org/0000-0003-4654-9085 Hong LiangState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
ZhenFeng ChenState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.
FuPing HuangState Key State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin 541004 PR China chenzf@gxnu.edu.cn huangfp2010@163.com.ORCID https://orcid.org/0000-0003-4227-9815 Guangxi Normal University · CNGuangxi University for Nationalities · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Based on 1,2-dimethoxyphenyl (veratrole, open) and 1,2-methylenedioxyphenyl (pepper ring, close)-derived pyridine-triazole analogues, two groups of copper(ii) complexes, namely, Group I(C1-C3) and Group II(C4-C6) were synthesized and fully characterized. All ligands and complexes were tested
Identifiers
PMID35496028
PMCPMC9049676
OpenAlexW3006513602
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390